KATHLEEN ROSENHAGEN: Open Payments
NPI 1902917404 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 30 payments from 10 companies in 2025. Trend: 2023 $728 · 2024 $577 · 2025 $665
Food & beverage: $575Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $235 |
| Sumitomo Pharma America, Inc. | 10 | $162 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $79 |
| ABBVIE INC. | 2 | $49 |
| Currax Pharmaceuticals LLC | 3 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Radius Health, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| MILLICENT US INC | 1 | $15 |
Products named: Veozah, MYFEMBREE, VRAYLAR, CONTRAVE, Lynkuet, Tymlos, Saxenda, GEMTESA.
Industry payments across TN — which companies pay providers there.
